Sertoli–Leydig cell tumors: an overview of key findings

Sertoli–Leydig cell tumors (SLCTs) are uncommon sex cord stromal tumors accounting for less than 0.5% of ovarian neoplasms, usually developing in women of reproductive age (average 25 years).[1][1] About half (40–60%) of patients present with androgenic manifestations (eg, virilization,